Rather than using single-modal antioxidant treatment that shows little success in slowing AD [231], co-activation of the Nrf2-ARE antioxidant system and neurotrophic signaling pathway would provide a better chance to modify the multifaceted disease, AD. The gene discussed is NFE2L2; the disease is Alzheimer disease.